NCT03699462View on ClinicalTrials.gov

The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

November 13, 2018

Primary Completion Date

October 17, 2020

Study Completion Date

October 17, 2020

Conditions
Coronary Artery Occlusive Disease(CAOD)
Interventions
DRUG

Plasma solution-A injection

The group receiving balanced crystalloid solution (Plasma solution-A injection, CJ Pharma, South Korea) during surgery

DRUG

5% Albumin

The group receiving 5% albumin (Albumin 5% inj, Green cross, South Korea) during surgery

Trial Locations (1)

03722

Division of Cardiac Anesthesiology, Department of Anesthesiology and Pain Medicine, Cardiovascular Hospital, Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03699462 - The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery | Biotech Hunter | Biotech Hunter